CH
EN
The login
丨
Quit
Integrate Drug Discovery Service
Service Flowchart
Service Coverage
In Vitro Biology
Enzymatic Assay
Cell Based Assay
Cell Proliferation Assay
PK-guided Cell Proliferation Assay (PCPA)
Screening with iPSC-derived tumor cells
CRISPR-Cas9 genome editing
Barcoded Ba/F3 cells stably expressing onco-kinase
In vitro Combination Study
wash-out experiment
DMPK
In Vitro ADME
Solubility Test
Microsome Stability Tests
Hepatocytes Stability Tests
CYP450 Inhibition
CaCO2 Permeability Test
MDCK-MDR Permeability Test
Plasma Protein Binding
Red Blood Cell Partitioning
Solubility Test
LogD
Microsome Stability Tests (Mouse, Rat, Dog, Monkey
Hepatocytes Stability Tests
CYP450 Inhibition (1A2,2C9,2C19,2D6,3A4)
CaCO2 Permeability Test
MDCK-MDR Permeability Test
Plasma Protein Binding
Red Blood Cell Partitioning (Blood/Plasma Ratio)
In Vivo DMPK
Single Dose PK
Dose Proportionality (Ascending Dose)
Dose Linearity (Multiple Dose)
Cassette PK (I.V.)
Blood-brain Barrier
Tissue Distribution
Mass Balance
Toxicokinectics
PK Formulation Screening And Optimization
Single Dose PK
Dose Proportionality (Ascending Dose)
Dose Linearity (Multiple Dose)
Cassette PK (I.V.)
Blood-brain Barrier
Tissue Distribution
Mass Balance
PK Formulation Screening And Optimization
PharmacoDynamics(PD)
PK-PD Relationship
In Vivo Efficacy
Syngeneic tumor models
Breast cancer models
Colorectal cancer models
Renal cancer models
Liver cancer models
Melanoma models
Pancreatic cancer models
Xenograft tumor Models
Breast cancer models
Colorectal cancer models
Epidermal cancer models
Gastric cancer models
Glioblastoma models
Leukemia models
Liver cancer models
Lung cancer models
Lymphoma models
Melanoma models
Ba/F3-derived cell models
Pancreatic cancer models
Ovarian cancer models
Prostate cancer models
PBMC-humanized Xenograft tumor Models
JeKo-1
A375
HCT116
Technology and Resources
Technology
Cell line establishment
Stem Cell Related
Enzymatic Assay Development and Validation
Animal Operation
Resources
Research Updates
Pipeline Analysis
Contact
Contact us
Honorary certificate
Vision and mission
About us
研究领域
Research filed
定量生物学
Quantitative Biology
DMPK
DMPK
体内药效学
In Vivo Efficacy
技术及资源
Technology and Resources
近期报道
Recent report
Learn More
DNA damage response (DDR)
2020-06-15
Objective to explore a new anti-cancer therapeutic strategy targeting various cellular DNA damage response (DDR) and DNA repair pathway
Read More
How to use tumor organs for tumor drug screening
2020-06-07
Before we go straight to how to use tumor-like organs for drug screening, a key question to answer is why - why not continue to use the standard in vitro drug screening platforms that are currently in use?
Read More
Integrate Drug Discovery Service
Service Flowchart
Service Coverage
In Vitro Biology
Enzymatic Assay
Cell Based Assay
Cell Proliferation Assay
PK-guided Cell Proliferation Assay (PCPA)
Screening with iPSC-derived tumor cells
CRISPR-Cas9 genome editing
Barcoded Ba/F3 cells stably expressing onco-kinase
In vitro Combination Study
wash-out experiment
DMPK
In Vitro ADME
Solubility Test
Microsome Stability Tests
Hepatocytes Stability Tests
CYP450 Inhibition
CaCO2 Permeability Test
MDCK-MDR Permeability Test
Plasma Protein Binding
Red Blood Cell Partitioning
Solubility Test
LogD
Microsome Stability Tests (Mouse, Rat, Dog, Monkey
Hepatocytes Stability Tests
CYP450 Inhibition (1A2,2C9,2C19,2D6,3A4)
CaCO2 Permeability Test
MDCK-MDR Permeability Test
Plasma Protein Binding
Red Blood Cell Partitioning (Blood/Plasma Ratio)
In Vivo DMPK
Single Dose PK
Dose Proportionality (Ascending Dose)
Dose Linearity (Multiple Dose)
Cassette PK (I.V.)
Blood-brain Barrier
Tissue Distribution
Mass Balance
Toxicokinectics
PK Formulation Screening And Optimization
Single Dose PK
Dose Proportionality (Ascending Dose)
Dose Linearity (Multiple Dose)
Cassette PK (I.V.)
Blood-brain Barrier
Tissue Distribution
Mass Balance
PK Formulation Screening And Optimization
PharmacoDynamics(PD)
PK-PD Relationship
In Vivo Efficacy
Syngeneic tumor models
Breast cancer models
Colorectal cancer models
Renal cancer models
Liver cancer models
Melanoma models
Pancreatic cancer models
Xenograft tumor Models
Breast cancer models
Colorectal cancer models
Epidermal cancer models
Gastric cancer models
Glioblastoma models
Leukemia models
Liver cancer models
Lung cancer models
Lymphoma models
Melanoma models
Ba/F3-derived cell models
Pancreatic cancer models
Ovarian cancer models
Prostate cancer models
PBMC-humanized Xenograft tumor Models
JeKo-1
A375
HCT116
Technology and Resources
Technology
Cell line establishment
Stem Cell Related
Enzymatic Assay Development and Validation
Animal Operation
Resources
Research Updates
Pipeline Analysis
Contact
Contact us
Honorary certificate
Vision and mission
About us
Copyright yourname allrights reserved All rights reserved:Suzhou Truway Biotechnology Inc.